4 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Pediarix®: new trials by email Literature Review of Pediarix® trials Research Report on Pediarix®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age Hib-MenCY-TT (MenHibrix®), Pediarix®, Rotarix® - Neisseria Meningitidis, Haemophilus Influenzae Type b | Phase 3 | Completed | GlaxoSmithKline | 600 | 2014-02-01 | 2018-09-14 |
| Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines Pentacel® (DTaP-IPV/Hib), Other Pertussis Vaccines - Pertussis | Completed | Sanofi Pasteur, a Sanofi Company | 1195 | 2010-02-08 | 2022-04-25 | |
| Database Surveillance Safety Study of PENTACEL® Vaccine DTaP-IPV/Hib, Other DTap Vaccines - Diphtheria, Tetanus | Completed | Sanofi Pasteur, a Sanofi Company | 62538 | 2008-09-01 | 2015-08-19 | |
| Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014 GSK Biologicals' Meningococcal vaccine GSK134612 (Nimenrix), GSK Biologicals' Hib-meningococcal vaccine GSK 792014 (Menhibrix), Infanrix® - Infections, Meningococcal | Phase 3 | Completed | GlaxoSmithKline | 1558 | 2008-02-13 | 2018-09-21 |
Haemophilus Infections (2) · Whooping Cough (2) · Diphtheria (1) · Meningococcal Infections (1) · Tetanus (1)
GlaxoSmithKline (2) · Sanofi Pasteur, a Sanofi Company (2)
United States (4)
PMID 25152325, PMID 25156560, PMID 25305567, PMID 27373595, PMID 32921507